SHL Telemedicine Ltd (SHLT) News

SHL Telemedicine erhält eine Kaufempfehlung mit einem Kursziel von $11,00

Ein führendes Aktienforschungsunternehmen gibt ein zweistelliges Kursziel für SHL Telemedicine an und positioniert das Unternehmen als eine...

SHL Telemedicine Receives Buy Rating with $11.00 Price Target

A leading equity research firm provides a double-digit price target for SHL Telemedicine, positioning it as an undervalued opportunity...

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24

The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13D - General statement of acquisition of beneficial ownership

Form SC 13D - General statement of acquisition of beneficial ownership

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

SHL Telemedicine German Operation and BARMER, one of the top health insurance funds in Germany, to present at leading Germany Healthcare...

SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US

A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service. SHL...

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits

Pioneering a New Era of Cardiac Care, SHL Telemedicine Established a Comprehensive Network to Broaden Access to Expert Cardiology Services for...

SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US

Making Significant Investments in Infrastructure and Technology, SHL Telemedicine Advances its US Direct-to-Consumer Strategy Post Positive...

SHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials

Promising outcomes indicate significant reductions in emergency visits and hospital readmissions, alongside reductions in healthcare utilization...

SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth

Regulatory News: SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of...

SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference

Initial results from the Mayo Clinic HELP-MI and the Imperial College London TELE-ACS trials to be presented...

SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023

SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023 PR Newswire TEL...